Benefits of biotechnology to pharmaceutical industry
Baichwal, R.S.
Hindustan Antibiotics Bulletin 30(3-4): 51-53
1988
ISSN/ISBN: 0018-1935 PMID: 3255744 Document Number: 314236
Document emailed within 1 workday
Related Documents
Hobden, A.N.; Harris, T.J.R. 1992: The impact of biotechnology and molecular biology on the pharmaceutical industry Proceedings of the Royal Society of Edinburgh Section B (Biological Sciences) 99(1-2): 37-45Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25
Mazza, P. 1993: Pharmaceutical biotechnology Bollettino Chimico Farmaceutico 132(7): 247-251
Ducatman, A.M.; Coumbis, J.J. 1991: Chemical hazards in the biotechnology industry Occupational Medicine 6(2): 193-208
Blium, I.B. 2002: Biotechnology in the modern world: benefits and risks Tsitologiia i Genetika 36(1): 59-79
Schlumberger, H.D.; Stadler, P. 1997: Modern pharmaceutical biotechnology. Situation worldwide and in Germany 1995 Arzneimittel-Forschung 47(1): 106-110
Lisella, F.S.; Herring, L.W. 1988: Promising biotechnology industry raises unique safety, health issues Occupational Health and Safety 57(6): 62
Hakim, Z.; Kucukarslan, S. 1993: Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States Clinical Therapeutics 15(2): 442-458; Discussion 432
Mackereth, M.B. 1988: Cost of pharmaceutical benefits New Zealand Medical Journal 101(849): 460-461
Neaverson, M.A. 1979: Cost of pharmaceutical benefits Medical Journal of Australia 2(9): 483
Feros, P.M. 1986: Pharmaceutical benefits scheme Medical Journal of Australia 145(8): 427
Louis, W.J.; O'Callaghan, C.J.; Krum, H.; Mander, A.G.; Louis, E.S. 1994: Pharmaceutical Benefits Scheme Medical Journal of Australia 161(2): 174
Schwarting, J.S. 2000: The pharmaceutical industry--to whom is it accountable? New England Journal of Medicine 343(19): 1416; Discussion 1417
Andersen, K. 1975: The responsibility of the pharmaceutical industry Nordisk Medicin 90(4): 115
Cohen, A.F. 2005: The pharmaceutical industry in uproar Nederlands Tijdschrift Voor Geneeskunde 149(19): 1074
Aumonier, J. 2003: Action of the pharmaceutical industry Annales Pharmaceutiques Francaises 61(6): 378-382
Kahn, M.F. 1984: More on rheumatology and the pharmaceutical industry Journal of Rheumatology 11(5): 717-718
Walker, A.M.; García Rodríguez, L.A.; Pérez Gutthann, S. 1992: Epidemiology and the pharmaceutical industry Medicina Clinica 98(12): 465-468
Henry, D.A.; Birkett, D.J. 2001: Changes to the Pharmaceutical Benefits Advisory Committee Medical Journal of Australia 174(5): 209-210
De Francisco, A.L.M. 2004: Medical doctors and pharmaceutical industry Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24(5): 393-394